Andrew Hindman
2015
In 2015, Andrew Hindman earned a total compensation of $1.2M as Chief Business Development Officer at Acorda Therapeutics, a 77% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $193,887 |
| Option Awards | $383,886 |
| Salary | $407,250 |
| Stock Awards | $150,644 |
| Other | $11,315 |
| Total | $1,196,982 |
Hindman received $407.3K in salary, accounting for 34% of the total pay in 2015.
Hindman also received $50K in bonus, $193.9K in non-equity incentive plan, $383.9K in option awards, $150.6K in stock awards and $11.3K in other compensation.
Rankings
In 2015, Andrew Hindman's compensation ranked 7,072nd out of 13,638 executives tracked by ExecPay. In other words, Hindman earned more than 48.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,072 out of 13,638 | 48th |
Division Manufacturing | 2,672 out of 5,190 | 49th |
Major group Chemicals And Allied Products | 960 out of 1,854 | 48th |
Industry group Drugs | 771 out of 1,528 | 50th |
Industry Biological Products, Except Diagnostic Substances | 135 out of 254 | 47th |
Source: SEC filing on April 21, 2017.
Hindman's colleagues
We found six more compensation records of executives who worked with Andrew Hindman at Acorda Therapeutics in 2015.
2015
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2015
Jane Wasman
Acorda Therapeutics
General Counsel
2015
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2015
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2015
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2015
David Lawrence
Acorda Therapeutics